NCT06058377 2026-04-16
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
National Cancer Institute (NCI)
Phase 3 Recruiting
Clinical Trials
11 trialsNCT06008392 2026-04-07
INTERCEPTioN
Mayo Clinic
Recruiting
NCT06632977 2026-04-07
PREDICT
Alliance for Clinical Trials in Oncology
Phase 2 Recruiting
NCT07091617 2026-04-07
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
Alliance for Clinical Trials in Oncology
Phase NA Recruiting
NCT04475640 2026-04-02
Cancer Genetic Testing in Ethnic Populations
Mayo Clinic
Phase NA Recruiting
NCT07498829 2026-03-27
PROTECT-C
Queen Mary University of London
Phase NA Recruiting
NCT03897374 2026-03-19
STOP-Cancer
ClinLogic LLC
Recruiting
NCT01772771 2026-03-03
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
M.D. Anderson Cancer Center
Recruiting
NCT05694559 2026-02-19
Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics
M.D. Anderson Cancer Center
Phase NA Recruiting
NCT06569316 2026-01-29
Genetic Testing for the Prevention of Cancer in Indigenous American Communities (JUNIPER Trial)
Mayo Clinic
Phase NA Recruiting
NCT04494945 2026-01-23
Identifying and Caring for Individuals With Inherited Cancer Syndrome
OHSU Knight Cancer Institute
Phase NA Recruiting